Interstitial inflammation and long-term renal outcomes in lupus nephritis

Lupus

Volumn 22, Issue 14, 2013, Pages 1446-1454

  Alsuwaida, A O ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

interstitial infiltrate; Lupus nephritis; renal function

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; COMPLEMENT; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTERSTITIAL INFLAMMATION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; REMISSION;

INTERSTITIAL INFILTRATE; LUPUS NEPHRITIS; RENAL FUNCTION;

ADOLESCENT; ADULT; BIOPSY; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LUPUS NEPHRITIS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84887916029     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313507986     Document Type: Article

References (23)

1. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003 ; 82: 299-308
2. Korbet SM, Schwartz MM, Evans J, Lewis EJ. Severe lupus nephritis: Racial differences in presentation and outcome. J Am Soc Nephrol. 2007 ; 18: 244-254
3. Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: A long-term clinicopathologic study. Lupus. 1995 ; 4: 109-115
4. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 2550-2557
5. Cook RJ, Gladman DD, Pericak D, Urositz MB. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol. 2000 ; 27: 1892-1895
6. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004 ; 65: 521-530
7. Williams W, Sargeant LA, Smilkle M, Smith R, Edwards H, Shah D. The outcome of lupus nephritis in Jamaican patients. Am J Med Sci. 2007 ; 334: 426-430
8. Esdaile J, Levinton C, Federgreen W, Hayslett JP, Kashgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: A study of 87 patients and review of the literature. Q J Med. 1989 ; 72: 779-833
9. Contreras G, Pardo V, Cely C, et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus. 2005 ; 14: 890-895
10. Schwartz MM, Fennell JS, Lewis EJ. Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol. 1982 ; 13: 534-547
11. Yu F, Wu LH, Tan Y, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology Renal Pathology Society system. Kidney Int. 2010 ; 77: 820-829
12. Neumann K, Wallace DJ, Azen C, et al. Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum. 1995 ; 25: 47-55
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
14. Pollak VE, Pirani CL, Schwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med. 1964 ; 63: 537-550
15. Austin HA 3rd, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983 ; 75: 382-391
16. Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res. 2011 ; 63: 865-874
17. Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ. Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol. 2008 ; 3: 46-53
18. Hill GS, Delahousse M, Nochy D, et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int. 2000 ; 58: 1160-1173
19. Mori Y, Kishimoto N, Yamahara H, et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis. Clin Exp Nephrol. 2005 ; 9: 79-84
20. Hayakawa S, Nakabayashi K, Karube M, et al. Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: Role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis. Clin Exp Nephrol. 2006 ; 10: 146-151
21. Omokawa A, Wakui H, Okuyama S, et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: Phenotype of infiltrating cells. Clin Nephrol. 2008 ; 69: 436-444
22. Hodgin JB, Whelan J, Markowitz GS, Stokes MB. Giant cell tubulitis with immune complex deposits in a patient with lupus nephritis. Am J Kidney Dis. 2009 ; 53: 513-517
23. Zhang X, Nagaraja HN, Nadasdy T, et al. A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int. 2012 ; 81: 401-406